Stock

GLAND

Gland Pharma Limited
Health Technology

Daily Margin Trading Facility book for GLAND across NSE and BSE, from 01 Jan 2025. All figures in ₹ crore, derived from exchange public disclosures.

Funded value
₹202 Cr
as of 10 Sep 2026
Rank in book
#179
286 days tracked
Share of book
0.13%
of the whole NSE + BSE book
Peak funded
₹208 Cr
on 08 Sep 2026
Largest single-day addition
+₹95 Cr
on 04 Sep 2026
Largest single-day unwind
−₹10 Cr
on 23 Jun 2026

NSE & BSE split

How GLAND’s funded book divides across the two exchanges, as of 10 Sep 2026.
NSE
NSE ₹199 Cr · 98.5%BSE ₹3 Cr · 1.5%

MTF vs Price

Margin-funded outstanding for GLAND in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹2,922.30
as of 11 Sep 2026
Price, 30 days
+16.8%
adjusted for splits and bonuses
Delivery, 20-day avg
52.6%
of traded volume actually settled
Sessions to unwind
2.5
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1 day+₹4+2.0%+1.9%
+13,494
−2.6%building as it falls
10 days+₹87+75.5%+64.2%
+2,85,988
+2.6%building into strength
30 days+₹86+73.7%+51.2%
+2,47,534
+17.1%building into strength
90 days+₹123+154.3%+106.9%
+3,77,706
+30.3%building into strength
180 days+₹175+643.4%+411.1%
+5,88,039
+76.6%building into strength
1 year+₹165+445.0%+204.9%
+4,91,307
+106.6%building into strength
Price is as of 11 Sep 2026; the MTF book is as of 10 Sep 2026. Exchanges publish the margin file a day after the market data, and the comparison above uses the MTF date for both sides.

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where GLAND has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

GLAND — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
10 Sep 2026202+₹40.13%179
09 Sep 2026198−₹100.13%182
08 Sep 2026208+₹80.14%174
07 Sep 2026200+₹60.13%182
04 Sep 2026194+₹950.13%186
03 Sep 2026100−₹40.07%374
02 Sep 2026104−₹70.07%355
01 Sep 2026111−₹30.07%337
31 Aug 2026114−₹00.07%328
28 Aug 2026114−₹10.07%329
27 Aug 2026115−₹10.08%325
26 Aug 2026116+₹10.08%324
25 Aug 2026115−₹30.08%323
24 Aug 2026118+₹20.08%318
21 Aug 2026117−₹00.08%320
20 Aug 2026117+₹10.08%320
19 Aug 2026116+₹10.08%318
18 Aug 2026116+₹10.08%321
17 Aug 2026114+₹30.08%322
14 Aug 2026111−₹50.07%328
13 Aug 2026116−₹90.08%322
12 Aug 2026125−₹40.09%296
11 Aug 2026128+₹160.09%278
10 Aug 2026113+₹140.08%318
07 Aug 202698+₹00.07%358
06 Aug 202698−₹30.07%360
05 Aug 2026101+₹20.07%353
04 Aug 202699−₹60.07%355
03 Aug 2026105−₹60.07%332
31 Jul 20261110.08%316

GLAND within Health Technology

Ranked #7 of 61 funded Health Technology stocks, carrying 3.2% of that sector’s margin book. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector
5SUNPHARMA
Sun Pharmaceutical Industries Limited
₹2804.4%
6DIVISLAB
Divi's Laboratories Limited
₹2664.2%
7GLAND
Gland Pharma Limited
₹2023.2%
8NATCOPHARM
Natco Pharma Limited
₹1903.0%
9DRREDDY
Dr. Reddy's Laboratories Limited
₹1702.7%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.